Repligen Corporation (FRA:RGN)

Germany flag Germany · Delayed Price · Currency is EUR
136.70
-1.30 (-0.94%)
Last updated: Jan 19, 2026, 8:17 AM CET
-17.38%
Market Cap7.08B -17.4%
Revenue (ttm)603.33M +11.7%
Net Income1.48M
EPS0.02
Shares Outn/a
PE Ratio4,777.66
Forward PE77.98
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume18
Open136.70
Previous Close138.00
Day's Range136.70 - 136.70
52-Week Range94.12 - 170.00
Betan/a
RSI35.59
Earnings DateFeb 19, 2026

About Repligen

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1981
Employees 1,778
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol RGN
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements